Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Metastatic Castration Resistant Prostate Cancer
×
enzalutamide
×
Clear all
Filters
3
NCT03177187
2024-09-26
ACE
Institute of Cancer Research, United Kingdom
Phase 1/2
Terminated
30 enrolled